Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19 - Concepedia

Concepedia

Publication | Open Access

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

DOI Full Paper Access

30

Citations

21

References

2022

Year

Flonza Isa, Eduardo Forleo‐Neto, Jonathan Meyer, Wenjun Zheng, Scott Rasmussen, Danielle Armas, Masaru Oshita, Cynthia Brinson, Steven Folkerth, Lori Faria,

International Journal of Infectious Diseases

References

	Year	Citations

Page 1